Covetrus, a private-equity-backed tech company for veterinary practices, is in preliminary talks to purchase Cencora Inc.'s veterinary business, according to a Bloomberg report from late Friday. CD&R, ...

Clayton Dubilier & Rice and TPG Inc. are in talks with private credit firms including Blue Owl Capital Inc. to line up at least $2.5 billion of debt for Covetrus, a technology company for veterinary ...

Multi-Color Corp. is planning to skip an interest payment due Thursday on some of its borrowings as the troubled label maker seeks to buy more time to negotiate a series of looming debt deadlines. The ...

Cornerstone Building Brands, Inc. ’s credit rating was downgraded by Moody’s Ratings for the second time in less than a year after the construction company was squeezed by higher costs driven by ...

Sealed Air's (SEE) sale to CD&R could see some investor pushback as the price is likely below expectations, according to a Wolfe Research analyst. "We sense that the deal value is below most buy-side ...

Sealed Air Corp. announced today it has reached an agreement to be acquired by Clayton, Dubilier and Rice (CD&R), a private investment firm with extensive experience in the industrial and packaging ...

Since 2011, FBM has a network of over 370 locations in the US Ruben Mendoza serves as CEO of FBM American Securities and CD&R have agreed to sell Foundation Building Materials, a Santa Ana, California ...

Claims that Cornerstone Building Brands Inc.‘s board manipulated the company’s forecasts amid pressure from Clayton, Dubilier & Rice LLC to approve a $5.8 billion take-private buyout will be resolved ...

These days, it has become very easy to watch your favorite movies and listen to top songs anytime, anywhere you want. There are music streaming platforms like Spotify where you can listen to your ...

CD&R, the private equity owner of Focus Financial Partners, has tapped Charles Schwab’s former CFO, Peter Crawford, as an operating advisor to help evaluate and select new investments in the financial ...

PARIS, Oct 21 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U.S.